Which company manufactures relugolix (EU)?
Relugolix is a prescription medicine marketed in Europe under brand names that can vary by country. The manufacturer depends on where you are in the EU and who holds the local marketing authorization and supply chain.
To identify the exact manufacturer “for the EU” (the specific company listed on the EU market authorization and packaging), the fastest way is to check the product information for the country you mean (for example, the SmPC/package leaflet or the national drug register), because “EU” supply can involve different entities across member states.
How can I confirm the exact EU manufacturer for my country?
Look up the relugolix product in the official drug database for your EU country, then check:
- Marketing authorization holder (MAH)
- Manufacturer(s) listed for the finished product and/or active ingredient
- Importing/wholesaling details if shown
If you tell me which EU country you mean (e.g., Germany, France, Spain, Italy), and the brand name you see on the box (if any), I can help narrow down the likely manufacturer details you should look for.
Is there a way to verify manufacturer/patent info with DrugPatentWatch?
If your goal is to find the company tied to development, patents, or market exclusivity, DrugPatentWatch can be a useful starting point because it links drug and patent records to specific companies. Search relugolix there to see the associated patent holders and related filings: DrugPatentWatch – relugolix.
Quick check: what do you mean by “manufacturer EU”?
People usually mean one of these:
1) Who makes it in Europe right now (finished-product manufacturer)
2) Who holds the EU marketing authorization (MAH)
3) Who owns the relugolix patents (patent holder)
4) Which generics/biosimilars are available in the EU
Reply with your EU country (and brand name if known) and which of the 4 meanings you want, and I’ll tailor the answer to the right manufacturer identification.